Nonsteroidal anti-inflammatory drugs and the gut

被引:12
作者
Hirschowitz, BI
机构
[1] Department of Medicine, Division of Gastroenterology, University of Alabama, Birmingham, AL
[2] Division of Gastroenterology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
关键词
D O I
10.1097/00007611-199603000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for analgesic, anti-inflammatory, and antithrombotic indications. Such use carries the risk of significant side effects on nontarget organs, especially the gut. Some of these effects may be serious, especially among the elderly, whose NSAID use is proportionately greatest. Upper gastrointestinal mucosal lesions range from trivial (petechiae and superficial erosions) to significant and potentially serious (chronic peptic ulcers, esophagitis, and small and large gut ulcers), The most serious side effects: are perforation of peptic or gut ulcers and gastrointestinal bleeding, which NSAIDs may promote from both ulcerous and nonulcerous lesions of both the upper and lower gastrointestinal tract, ie, both acid-dependent and non-acid-dependent. Symptoms may be independent of observable lesions, and serious lesions may occur without previous symptoms. NSAIDs may also delay healing of peptic ulcers, even to the extent of intractability, and may cause recurrence after gastric surgery. Until we can separate the mechanisms whereby NSAIDs both cause injury and provide therapeutic benefits, the problem of side effects and their prevention or treatment remains unresolvable.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 20 条
[1]   MODES OF ACTION OF ASPIRIN-LIKE DRUGS [J].
ABRAMSON, S ;
KORCHAK, H ;
LUDEWIG, R ;
EDELSON, H ;
HAINES, K ;
LEVIN, RI ;
HERMAN, R ;
RIDER, L ;
KIMMEL, S ;
WEISSMANN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) :7227-7231
[2]   GASTROINTESTINAL DAMAGE ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ALLISON, MC ;
HOWATSON, AG ;
TORRANCE, CJ ;
LEE, FD ;
RUSSELL, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) :749-754
[3]  
BARRIER CH, 1989, ARTHRITIS RHEUM, V32, P926
[4]   CLINICAL MANAGEMENT OF RHEUMATOID-ARTHRITIS [J].
BROOKS, PM .
LANCET, 1993, 341 (8840) :286-290
[5]  
BROOKS PM, 1991, NEW ENGL J MED, V324, P1716
[6]   DUODENAL AND GASTRIC-ULCER PREVENTION WITH MISOPROSTOL IN ARTHRITIS PATIENTS TAKING NSAIDS [J].
GRAHAM, DY ;
WHITE, RH ;
MORELAND, LW ;
SCHUBERT, TT ;
KATZ, R ;
JASZEWSKI, R ;
TINDALL, E ;
TRIADAFILOPOULOS, G ;
STROMATT, SC ;
TEOH, LS .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (04) :257-262
[7]  
Hirschowitz B I, 1994, Gastroenterologist, V2, P207
[8]  
KOLATA G, 1994, NY TIMES 1021
[9]   THE EFFECT OF CHRONIC ASPIRIN USE ON DUODENAL AND GASTRIC-ULCER HOSPITALIZATIONS [J].
KURATA, JH ;
ABBEY, DE .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1990, 12 (03) :260-266
[10]   SIGNIFICANT ROLE OF ASPIRIN USE IN PATIENTS WITH ESOPHAGITIS [J].
LANAS, A ;
HIRSCHOWITZ, BI .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1991, 13 (06) :622-627